Provenance du réseau au premier degré de Mann Muhsin
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 16 | |
| Public Company | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mann Muhsin via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing | |
| HOLOGIC, INC. | Medical Specialties | Public Communications Contact | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Public Communications Contact | |
| ONCOLYTICS BIOTECH INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Medical Specialties | Investor Relations Contact | |
| GENOCEA BIOSCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| VISTERRA INC | Pharmaceuticals: Major | Director/Board Member | |
Gradalis, Inc.
 Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | Pharmaceuticals: Major | Chief Executive Officer | |
SF Capital Group LLC
 SF Capital Group LLC Investment ManagersFinance SF Capital Group LLC (SF Capital) is a private equity firm founded in 2009. The firm is headquartered in New York. | Investment Managers | Director/Board Member | |
| TURG POIN | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree | |
| MIRATI THERAPEUTICS | Biotechnology | Chief Operating Officer Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
| Boston College | College/University | Undergraduate Degree | |
| The University of Chicago | College/University | Doctorate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
University of Akron
 University of Akron Other Consumer ServicesConsumer Services University of Akron provides public research education. Its programs include under graduate studies, graduate studies, international studies, law, and continuing education. The company was founded in 1870 and is headquartered in Akron, OH. | College/University | Masters Business Admin | |
| University of Kansas | College/University | Undergraduate Degree | |
| University of Manitoba | College/University | Doctorate Degree | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree | |
| University of Mumbai | College/University | Graduate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| The Fuqua School of Business | College/University | Masters Business Admin | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
| Saint Louis University School of Medicine | College/University | Corporate Officer/Principal | |
| Boys & Girls Clubs of New Jersey | Director/Board Member | ||
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
Denovo Biopharma LLC
 Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SYNEOS HEALTH, INC. | Biotechnology | Director/Board Member | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chairman |
Statistiques
Internationale
| Etats-Unis | 42 |
| Canada | 3 |
| Royaume-Uni | 2 |
| Inde | 2 |
| Danemark | 2 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 51 |
| Corporate Officer/Principal | 36 |
| Independent Dir/Board Member | 23 |
| Chief Tech/Sci/R&D Officer | 17 |
| Chairman | 15 |
Relations les plus connectées
| Insiders | |
|---|---|
| Kathryn Falberg | 30 |
| Randal Kirk | 20 |
| Athena Countouriotis | 17 |
| Mark Gergen | 13 |
| Bernadette Connaughton | 10 |
| Albert Kildani | 9 |
| H. Shepard | 9 |
| Benjamin Hickey | 9 |
| Thomas Heineman | 7 |
| Jeff Knight | 7 |
| Jim Mazzola | 6 |
| Homa Yeganegi | 6 |
| Masaru Matsuda | 5 |
| Steve Knowles | 5 |
| John Sampson | 5 |
- Bourse
- Insiders
- Mann Muhsin
- Connexions Sociétés
